Jones Financial Companies Lllp Lowers Stock Position in iShares U.S. Pharmaceuticals ETF $IHE

Jones Financial Companies Lllp trimmed its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 30.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 19,377 shares of the company’s stock after selling 8,364 shares during the period. Jones Financial Companies Lllp’s holdings in iShares U.S. Pharmaceuticals ETF were worth $1,361,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Harbor Asset Planning Inc. purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter worth $27,000. Mather Group LLC. acquired a new position in iShares U.S. Pharmaceuticals ETF during the third quarter worth $38,000. CX Institutional raised its holdings in iShares U.S. Pharmaceuticals ETF by 2,665.5% during the third quarter. CX Institutional now owns 802 shares of the company’s stock worth $58,000 after purchasing an additional 773 shares during the last quarter. Hudock Inc. purchased a new stake in iShares U.S. Pharmaceuticals ETF during the third quarter worth $212,000. Finally, Wealth Enhancement Advisory Services LLC grew its stake in iShares U.S. Pharmaceuticals ETF by 6.0% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 4,207 shares of the company’s stock valued at $316,000 after acquiring an additional 240 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

IHE stock opened at $89.97 on Wednesday. The company’s 50 day simple moving average is $85.85 and its 200-day simple moving average is $77.95. iShares U.S. Pharmaceuticals ETF has a 12 month low of $58.97 and a 12 month high of $90.80. The firm has a market capitalization of $1.01 billion, a PE ratio of 17.75 and a beta of 0.54.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.